BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

73 related articles for article (PubMed ID: 26813079)

  • 1. Triplets with neonatal alloimmune thrombocytopenia due to antibodies against human platelet antigen 1a.
    Solh Z; Breakey V; Murthy P; Smith JW; Arnold DM
    Transfusion; 2016 May; 56(5):1166-1170. PubMed ID: 26813079
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Management of infants born with severe neonatal alloimmune thrombocytopenia: the role of platelet transfusions and intravenous immunoglobulin.
    Bakchoul T; Bassler D; Heckmann M; Thiele T; Kiefel V; Gross I; Arnold DM; DiTomasso J; Smith JW; Paes B; Greinacher A
    Transfusion; 2014 Mar; 54(3):640-5. PubMed ID: 23869512
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Intrauterine use of hyperconcentrated platelet concentrates collected with Trima Accel in a case of neonatal alloimmune thrombocytopenia.
    Ringwald J; Schroth M; Faschingbauer F; Strobel J; Strasser E; Schild RL; Goecke TW
    Transfusion; 2007 Aug; 47(8):1488-93. PubMed ID: 17655593
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Blockade of maternal anti-HPA-1a-mediated platelet clearance by an HPA-1a epitope-specific F(ab') in an in vivo mouse model of alloimmune thrombocytopenia.
    Bakchoul T; Boylan B; Sachs UJ; Bein G; Ruan C; Santoso S; Newman PJ
    Transfusion; 2009 Feb; 49(2):265-70. PubMed ID: 19000229
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Severe HPA-15b related neonatal alloimmune thrombocytopenia.
    Moncharmont P; Courvoisier S; Pagnier A; Cotta L; Debillon T; Rigal D
    Acta Paediatr; 2007 Nov; 96(11):1701-3. PubMed ID: 17850392
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Recipient-derived HPA-1a antibodies: a cause of prolonged thrombocytopenia after unrelated donor stem cell transplantation.
    Lucas G; Culliford S; Green F; Sidra G; Calvert A; Green A; Harrison P; Harvey J; Allen D; Smillie D; Masurekar A; Marks D; Russell N; Massey E
    Transfusion; 2010 Feb; 50(2):334-9. PubMed ID: 19874563
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Rapid detection of HPA-1 alloantibodies by platelet antigens immobilized onto microbeads.
    Bakchoul T; Meyer O; Agaylan A; Bombard S; Bein G; Sachs UJ; Salama A; Santoso S
    Transfusion; 2007 Aug; 47(8):1363-8. PubMed ID: 17655579
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Toward a prophylaxis against fetal and neonatal alloimmune thrombocytopenia: induction of antibody-mediated immune suppression and prevention of severe clinical complications in a murine model.
    Tiller H; Killie MK; Chen P; Eksteen M; Husebekk A; Skogen B; Kjeldsen-Kragh J; Ni H
    Transfusion; 2012 Jul; 52(7):1446-57. PubMed ID: 22251227
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Direct comparison between two quantitative assays in the measurement of maternal anti-HPA-1a antibody in neonatal alloimmune thrombocytopenia (NAIT).
    Bessos H; Killie MK; Matviyenko M; Husebekk A; Urbaniak SJ
    Transfus Apher Sci; 2008 Dec; 39(3):221-7. PubMed ID: 18945639
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Neonatal alloimmune thrombocytopenia due to HPA-3a antibodies: a case report.
    Davoren A; Smith G; Lucas G; Rodgers S; O'Donoghue P; Crowley J; Barnes CA; McKiernan J
    Immunohematology; 2002; 18(2):33-6. PubMed ID: 15373561
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Maternal human platelet antigen-1a antibody level correlates with the platelet count in the newborns: a retrospective study.
    Killie MK; Husebekk A; Kaplan C; Taaning E; Skogen B
    Transfusion; 2007 Jan; 47(1):55-8. PubMed ID: 17207230
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Neonatal alloimmune thrombocytopenia due to anti-HPA-5b (Bra).
    Campbell-Lee SA; DeSantis-Parsons D; Shirey RS; Kickler TS
    Immunohematology; 2003; 19(4):127-31. PubMed ID: 15373678
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Neonatal alloimmune thrombocytopenia].
    Ohto H
    Nihon Rinsho; 1997 Sep; 55(9):2310-4. PubMed ID: 9301295
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Neonatal alloimmune thrombocytopenia due to anti-HPA-2b (anti-Koa).
    Goldman M; Trudel E; Richard L; Khalife S; Spurll GM
    Immunohematology; 2003; 19(2):43-6. PubMed ID: 15373693
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Neonatal alloimmune thrombocytopenia].
    Schechter Y; Zeides I; Shalev E; Sharon R
    Harefuah; 1994 Dec; 127(12):505-8, 576. PubMed ID: 7813921
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Neonatal alloimmune thrombocytopenia due to anti-HPA-1b (PLA2)(Zwb). A case report and review.
    Winters JL; Jennings CD; Desai NS; Dickson LG; Ford RF
    Vox Sang; 1998; 74(4):256-9. PubMed ID: 9691408
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The first case of alloantibody against human platelet antigen-15b in Japan: possible alloimmunization by a hydatidiform mole.
    Matsuhashi M; Tsuno NH; Kawabata M; Yokoyama T; Tazaki Y; Takashima T; Oda H; Kuroda Y; Nagayoshi Y; Morita S; Shibata Y; Santoso S; Takahashi K
    Transfusion; 2010 May; 50(5):1126-30. PubMed ID: 20030792
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Anti-HPA-9bw (Maxa) fetomaternal alloimmunization, a clinically severe neonatal thrombocytopenia: difficulties in diagnosis and therapy and report on eight families.
    Kaplan C; Porcelijn L; Vanlieferinghen P; Julien E; Bianchi F; Martageix C; Bertrand G; Jallu V
    Transfusion; 2005 Nov; 45(11):1799-803. PubMed ID: 16271107
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Neonatal alloimmune thrombocytopenia due to HPA-9b incompatibility.
    Raj A; Kailasnath VP; Bertolone S; McFarland JG
    Pediatr Blood Cancer; 2009 Sep; 53(3):459-61. PubMed ID: 19459189
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Usefulness of maternal anti-HPA-1a antibody quantitation in predicting severity of foetomaternal alloimmune thrombocytopenia.
    Sainio S; Javela K; Tuimala J; Koskinen S
    Transfus Med; 2013 Apr; 23(2):114-20. PubMed ID: 23448161
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.